Evidence map›Paper›PMID 21593153›Full record

ArticleJournal of virology2011

Reduction of CD4+ T cells in vivo does not affect virus load in macaque elite controllers.

Philip A Mudd, Adam J Ericsen, Andrew A Price, Nancy A Wilson, Keith A Reimann, David I Watkins

Abstract read
In one paragraph

Article in Journal of virology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. CD8Nature reviews. Immunology · 2020
    Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. A novel monoclonal antibody to CD40 prolongs islet allograft survival.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2012
    Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Philip A MuddDepartment of Pathology and Laboratory Medicine, University of Wisconsin-Madison, 555 Science Dr., Madison, WI 53711, USA.
Adam J Ericsen
Andrew A Price
Nancy A Wilson
Keith A Reimann
David I Watkins

Funding

ZOLEDRONATE PREVENTS BONE LOSS IN OVARIECTOMIZED RHESUS MONKEYSP51RR000167 · NCRR · UNIVERSITY OF WISCONSIN-MADISON · PI WATKINS, DAVID I · 1985 to 2011
$106.7M
The impact of HIV viral diversity and cellular immunity on HIV pathogenesisP30AI060354 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI ROBERT A. PARKER · 2004 to 2026
$94.4M
INTEGRATED TRAINING FOR PHYSICIAN-SCIENTISTST32GM008692 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI BURKARD, MARK E · 1998 to 2020
$10.3M
RESOURCE FOR NONHUMAN PRIMATE CELL DEPLETING ANTIBODIESR24RR016001 · NCRR · BETH ISRAEL DEACONESS MEDICAL CENTER · PI REIMANN, KEITH A. · 2000 to 2011
$8.1M
MHC-bound, SIV-derived, CTL &HTL EpitopesR24RR015371 · NCRR · UNIVERSITY OF WISCONSIN-MADISON · PI WATKINS, DAVID I · 2000 to 2011
$8.1M
A NOVEL, LOGICAL APPROACH TO HIV VACCINE DEVELOPMENTR01AI049120 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI WATKINS, DAVID I · 2001 to 2009
$7.6M
The Functional Significance of CTL EscapeR37AI052056 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI WATKINS, DAVID I · 2008 to 2017
$7.1M
MHC TYPING OF MACAQUES USED IN AIDS RESEARCHR24RR016038 · NCRR · UNIVERSITY OF WISCONSIN-MADISON · PI WATKINS, DAVID I · 2001 to 2011
$6.3M
Resource for Nonhuman Primate Cell Depleting AntibodiesR24OD010976 · OD · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI ENGELMAN, KATHLEEN, MAGNANI, DIOGO · 2012 to 2019
$4.7M
Minigene Vaccination with Early Presented Viral ProteinsR01AI076114 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI RAKASZ, EVA GIZELLA · 2007 to 2011
$3.3M
Virology Training ProgramT32AI078985 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI LAMBERT, PAUL F. · 2009 to 2018
$3.3M
NCRR NIH HHS P51 RR000167NCRR NIH HHS R24 RR015371NCRR NIH HHS R24 RR016001NCRR NIH HHS R24 RR016038NIAID NIH HHS HHSN272200900037CNIAID NIH HHS P30 AI060354NIAID NIH HHS R01 AI049120NIAID NIH HHS R01 AI076114NIAID NIH HHS R37 AI052056NIAID NIH HHS T32 AI078985NIGMS NIH HHS T32 GM008692PHS HHS 272200900037CPHS HHS R21 PRJ27JP
6 · The paper itself

Abstract

A small percentage of human immunodeficiency virus (HIV)- and simian immunodeficiency virus (SIV)-infected individuals spontaneously control virus replication. The majority of these elite controllers mount high-frequency virus-specific CD4(+) T cell responses. To evaluate the role these responses might play in viral control, we depleted two elite controller macaques of CD4(+) cells. SIV-specific CD4(+) T cell responses did not return to baseline levels until 8 weeks postdepletion. Viral loads remained stable throughout the experiment, suggesting that SIV-specific CD4(+) T cell responses may not play a direct role in controlling chronic viral replication in these elite controllers.

Indexed as

CD4-Positive T-LymphocytesViral LoadAnimalsBase SequenceDNA PrimersMacaca mulattaReverse Transcriptase Polymerase Chain ReactionSimian Immunodeficiency VirusVirus ReplicationDNA Primers

Identifiers

PMID21593153
PMCPMC3126606

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.